| GP88 (GRN) | progranulin |
| BCa | bladder cancer |
| TCs | tumor cells |
| ICs | immune cells |
| IHC | immunohistochemistry |
| OS | overall survival |
| DSS | disease-specific survival |
| RFS | recurrence free survival |
| CD3 | CD3 antigen |
| CD8 | CD8 antigen |
| PD1 (PDCD1) | Programmed cell death protein 1 |
| PD-L1 (CD274) | Programmed cell death ligand 1 |
| CD68 | CD68 antigen |
| CD163 | CD163 antigen |
| CCL2 | chemokine CC motif ligand 2 |
| pT | pathological tumor stage |
| pN | pathological lymph node stage |
| n.s. | not significant |
| DN | double negative (for basal and luminal markers) |
| MUPC | micropapillary urothelial carcinoma |
| NOS | not otherwise specified (morphology) |
| PUC | plasmacytoid urothelial carcinoma |